Cargando…

Antiplatelet Agents Affecting GPCR Signaling Implicated in Tumor Metastasis

Metastasis requires that cancer cells survive in the circulation, colonize distant organs, and grow. Despite platelets being central contributors to hemostasis, leukocyte trafficking during inflammation, and vessel stability maintenance, there is significant evidence to support their essential role...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rovati, Gianenrico, Contursi, Annalisa, Bruno, Annalisa, Tacconelli, Stefania, Ballerini, Patrizia, Patrignani, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8870128/ https://www.ncbi.nlm.nih.gov/pubmed/35203374 http://dx.doi.org/10.3390/cells11040725

Ejemplares similares

Antithrombotic Agents and Cancer
por: Bruno, Annalisa, et al.
Publicado: (2018)

The antiplatelet agent revacept prevents the increase of systemic thromboxane A(2) biosynthesis and neointima hyperplasia
por: Alberti, Sara, et al.
Publicado: (2020)

Inflammation and Cancer: From the Development of Personalized Indicators to Novel Therapeutic Strategies
por: Ballerini, Patrizia, et al.
Publicado: (2022)

P2Y(12) Receptors in Tumorigenesis and Metastasis
por: Ballerini, Patrizia, et al.
Publicado: (2018)

Multifaceted Functions of Platelets in Cancer: From Tumorigenesis to Liquid Biopsy Tool and Drug Delivery System
por: Dovizio, Melania, et al.
Publicado: (2020)

Characterization of the acetylation of cyclooxygenase-isozymes and targeted lipidomics of eicosanoids in serum and colon cancer cells by the new aspirin formulation IP1867B versus aspirin in vitro
por: Hofling, Ulrika, et al.
Publicado: (2022)

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients
por: Lanas, Angel, et al.
Publicado: (2023)

Grand Challenges in Pharmacotherapy of Inflammation for the First Decades of the 21st Century
por: Patrignani, Paola, et al.
Publicado: (2010)

Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells
por: Contursi, Annalisa, et al.
Publicado: (2023)

Platelets induce free and phospholipid-esterified 12-hydroxyeicosatetraenoic acid generation in colon cancer cells by delivering 12-lipoxygenase
por: Contursi, Annalisa, et al.
Publicado: (2021)

Mechanistic and Pharmacological Issues of Aspirin as an Anticancer Agent
por: Dovizio, Melania, et al.
Publicado: (2012)

Chemokine/GPCR Signaling-Mediated EMT in Cancer Metastasis
por: Tian, Xutengyue, et al.
Publicado: (2022)

Inside epoxyeicosatrienoic acids and cardiovascular disease
por: Tacconelli, Stefania, et al.
Publicado: (2014)

Risk management profile of etoricoxib: an example of personalized medicine
por: Patrignani, Paola, et al.
Publicado: (2008)

New Routes in GPCR/β-Arrestin-Driven Signaling in Cancer Progression and Metastasis
por: Bagnato, Anna, et al.
Publicado: (2019)

Multiple GPCR conformations and signalling pathways: implications for antagonist affinity estimates
por: Baker, Jillian G., et al.
Publicado: (2007)

GPCR oligomers in pharmacology and signaling
por: González-Maeso, Javier
Publicado: (2011)

GPCR-Hippo Signaling in Cancer
por: Luo, Jiaqian, et al.
Publicado: (2019)

GPCR Conformations: Implications for Rational Drug Design
por: Parrill, Abby L., et al.
Publicado: (2010)

Editorial: Insights in inflammation pharmacology: 2022
por: Patrignani, Paola, et al.
Publicado: (2023)

Statement on Antiplatelet Agents and Anticoagulants in Cardiology - 2019
por: Serrano Jr., Carlos V., et al.
Publicado: (2019)

Kinetics of the early events of GPCR signalling
por: Adamson, Roslin J., et al.
Publicado: (2014)

Fungal GPCR signaling in pheromone response
por: Kothe, E, et al.
Publicado: (2009)

Rho GTPase Signaling in Platelet Regulation and Implication for Antiplatelet Therapies
por: Dandamudi, Akhila, et al.
Publicado: (2023)

Signaling Modification by GPCR Heteromer and Its Implication on X-Linked Nephrogenic Diabetes Insipidus
por: Ng, Hans K. H., et al.
Publicado: (2016)

Ticagrelor: An emerging oral antiplatelet agent
por: Juneja, Shivani, et al.
Publicado: (2013)

Patterns of antiplatelet agent use in the US
por: Kanakadandi, Vijay, et al.
Publicado: (2015)

Editorial: Antiplatelet Agents in Stroke Prevention
por: Feher, Gergely, et al.
Publicado: (2021)

DREADD: A Chemogenetic GPCR Signaling Platform
por: Zhu, Hu, et al.
Publicado: (2014)

GPCR-bigrams: Enigmatic signaling components in oomycetes
por: van den Hoogen, Johan, et al.
Publicado: (2018)

GPCR Signaling Regulation: The Role of GRKs and Arrestins
por: Gurevich, Vsevolod V., et al.
Publicado: (2019)

Latrophilin GPCR signaling mediates synapse formation
por: Sando, Richard, et al.
Publicado: (2021)

Hypothalamic GPCR Signaling Pathways in Cardiometabolic Control
por: Deng, Yue, et al.
Publicado: (2021)

The Impact of Membrane Protein Diffusion on GPCR Signaling
por: Boltz, Horst-Holger, et al.
Publicado: (2022)

Intracellular VHHs to monitor and modulate GPCR signaling
por: Raynaud, Pauline, et al.
Publicado: (2022)

Subcellular location defines GPCR signal transduction
por: Radoux-Mergault, Arthur, et al.
Publicado: (2023)

The landscape of cancer rewired GPCR signaling axes
por: Arora, Chakit, et al.
Publicado: (2023)

Structure, function and drug discovery of GPCR signaling
por: Cheng, Lin, et al.
Publicado: (2023)

Reciprocal interference between the NRF2 and LPS signaling pathways on the immune‐metabolic phenotype of peritoneal macrophages
por: Mornata, Federica, et al.
Publicado: (2020)

Newer agents in antiplatelet therapy: a review
por: Yeung, Jennifer, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_295sodbgaggo6lj2qtfo1i9s1t